Clinical trial
A Randomized Controlled Multicenter Trial Examining the Effect of Derm-Maxx ADM on the Healing Rate of Chronic Diabetic Foot Ulcers
NCT06455475 is registered in ClinicalTrials.gov with Capsicure, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Multicenter Trial Examining the Effect of Derm-Maxx ADM on the Healing Rate of Chronic Diabetic Foot Ulcers
- Lead sponsor
- Capsicure, LLC
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 25, 2024
- Completion date
- May 22, 2026
- Enrollment
- 120 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer